Growth Differentiation Factor 15 and Risk of Death in Haemodialysis Patients
Aim. Noninvasive identification of haemodialysis patients at high risk of cardiovascular events and death might improve their outcome. Growth differentiation factor 15 is a prognostic biomarker in multiple disease entities, including cardiovascular disease. The aim of this study was to assess the as...
Saved in:
Main Authors: | Christelle Calen, Seraina Von Moos, Pietro Cippà, Alexandre Mebazaa, Mattia Arrigo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | International Journal of Nephrology |
Online Access: | http://dx.doi.org/10.1155/2023/5163548 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibiogram for Haemodialysis Catheter-Related Bloodstream Infections
by: Abdul Halim Abdul Gafor, et al.
Published: (2014-01-01) -
Ethics in the nursing care to patients on haemodialysis treatment
by: Janairy Rosales Origuela, et al.
Published: (2016-10-01) -
Serum Growth Differentiation Factor 15 is Negatively Associated with Leukocyte Telomere Length
by: Jie Yu, et al.
Published: (2025-04-01) -
Glycaemic Control Impact on Renal Endpoints in Diabetic Patients on Haemodialysis
by: Danielle Creme, et al.
Published: (2015-01-01) -
A SCOPING REVIEW OF MHEALTH TECHNOLOGIES FOR PATIENTS UNDERGOING HAEMODIALYSIS
by: Sarah Amalia, et al.
Published: (2024-12-01)